Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

New medications could improve treatment for severe alopecia areata in Australia.

Both treatments improved hair quality and thickness equally, with mild side effects.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Raltegravir may cause hair loss in some patients.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

The treatment was not recommended due to limited effectiveness and significant side effects.

Baricitinib is effective for severe alopecia areata but has some side effects.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib was effective in treating both early and late onset alopecia areata.